---
document_datetime: 2025-07-18 15:16:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aldara-epar-all-authorised-presentations_en.pdf
document_name: aldara-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.860172
conversion_datetime: 2025-12-14 16:22:29.475206
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging              | Content   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|------------------------|-----------|----------------|
| EU/1/98/080/001 | Aldara          | 5% w/w     | Cream                 | Cutaneous use             | sachet (polyester/alu) | 250 mg    | 12 sachets     |
| EU/1/98/080/002 | Aldara          | 5% w/w     | Cream                 | Cutaneous use             | sachet (polyester/alu) | 250 mg    | 24 sachets     |